[ Price : $8.95]
FDA accepts for review a Genentech supplemental BLA for Avastin (bevacizumab) for its use in combination with chemotherapy, follow...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Breakthrough Devices Program; Draft Guidance for Industry a...[ Price : $8.95]
FDAs Los Angeles District issues a nine-page Warning Letter to an OTC drug manufacturer that allegedly makes topical pain drugs in...[ Price : $8.95]
Four congressional Democrats introduce a bill to require HHS to negotiate prices for Medicare Part D covered drugs.[ Price : $8.95]
FDA issues two draft guidances on a systematic, risk-based approach to evaluating drug-drug interactions.[ Price : $8.95]
Federal Register notice: FDA makes available two draft guidances entitled In Vitro Metabolism- and Transporter-Mediated Drug-Drug ...[ Price : $8.95]
FDA approves an Alexion Pharmaceuticals supplemental BLA for Soliris (eculizumab) as a treatment for adult patients with generaliz...[ Price : $8.95]
FDA Oncology Center of Excellence staff outlines steps to promote greater use of real-world evidence in cancer trials.